Which has preferable valuation and earnings, CVRX or MOBI?

Mobia Medical has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $61.19M 1.34 -$53.31M -$1.98 N/A Mobia Medical $32.04M 12.56 -$46.50M -$20.18 N/A

Is CVRX or MOBI more profitable?

Mobia Medical has a net margin of 0.00% compared to CVRx's net margin of -84.93%. Mobia Medical's return on equity of 0.00% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Mobia Medical N/A N/A N/A

Does the media prefer CVRX or MOBI?

In the previous week, CVRx and CVRx both had 3 articles in the media. CVRx's average media sentiment score of 0.47 beat Mobia Medical's score of -0.33 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mobia Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, CVRX or ELMD?

Electromed has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $61.19M 1.34 -$53.31M -$1.98 N/A Electromed $73.78M 3.20 $5.15M $1.31 21.56

Is CVRX or ELMD more profitable?

Electromed has a net margin of 11.34% compared to CVRx's net margin of -84.93%. Electromed's return on equity of 15.71% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Electromed 11.34% 15.71% 13.37%

Does the media refer more to CVRX or ELMD?

In the previous week, CVRx had 1 more articles in the media than Electromed. MarketBeat recorded 3 mentions for CVRx and 2 mentions for Electromed. Electromed's average media sentiment score of 0.55 beat CVRx's score of 0.47 indicating that Electromed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Electromed 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, CVRX or RCEL?

Avita Medical has higher revenue and earnings than CVRx. Avita Medical is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $61.19M 1.34 -$53.31M -$1.98 N/A Avita Medical $71.61M 4.62 -$48.59M -$1.44 N/A

Is CVRX or RCEL more profitable?

Avita Medical has a net margin of -56.96% compared to CVRx's net margin of -84.93%. Avita Medical's return on equity of 0.00% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Avita Medical -56.96% N/A -78.53%

Does the media refer more to CVRX or RCEL?

In the previous week, CVRx had 2 more articles in the media than Avita Medical. MarketBeat recorded 3 mentions for CVRx and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.00 beat CVRx's score of 0.47 indicating that Avita Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CVRX or OBIO more profitable?

CVRx has a net margin of -84.93% compared to Orchestra BioMed's net margin of -184.60%. Orchestra BioMed's return on equity of -149.61% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Orchestra BioMed -184.60% -149.61% -54.15%

Does the media prefer CVRX or OBIO?

In the previous week, Orchestra BioMed had 4 more articles in the media than CVRx. MarketBeat recorded 7 mentions for Orchestra BioMed and 3 mentions for CVRx. Orchestra BioMed's average media sentiment score of 1.19 beat CVRx's score of 0.47 indicating that Orchestra BioMed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Orchestra BioMed 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CVRX or TMCI?

In the previous week, CVRx had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 3 mentions for CVRx and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.34 beat CVRx's score of 0.47 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

CVRx (CVRX) Competitors

$3.07 +0.03 (+0.99%)

Closing price 09/2/2026 04:00 PM Eastern

Extended Trading

$3.04 -0.03 (-1.11%)

As of 05:01 AM Eastern

Compare

CVRX vs. MOBI, ELMD, RCEL, OBIO, and TMCI

Should you buy CVRx stock or one of its competitors? CVRx's main competitors and comparable companies include Mobia Medical (MOBI), Electromed (ELMD), Avita Medical (RCEL), Orchestra BioMed (OBIO), and Treace Medical Concepts (TMCI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does CVRx compare to Mobia Medical?

CVRx (NASDAQ:CVRX) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Mobia Medical has a net margin of 0.00% compared to CVRx's net margin of -84.93%. Mobia Medical's return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Mobia Medical	N/A	N/A	N/A

75.3% of CVRx shares are held by institutional investors. 16.6% of CVRx shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Mobia Medical has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$61.19M	1.34	-$53.31M	-$1.98	N/A
Mobia Medical	$32.04M	12.56	-$46.50M	-$20.18	N/A

CVRx presently has a consensus target price of $5.30, indicating a potential upside of 72.64%. Mobia Medical has a consensus target price of $20.75, indicating a potential upside of 71.63%. Given CVRx's higher probable upside, research analysts clearly believe CVRx is more favorable than Mobia Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

In the previous week, CVRx and CVRx both had 3 articles in the media. CVRx's average media sentiment score of 0.47 beat Mobia Medical's score of -0.33 indicating that CVRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mobia Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Mobia Medical beats CVRx on 8 of the 14 factors compared between the two stocks.

How does CVRx compare to Electromed?

CVRx (NASDAQ:CVRX) and Electromed (NYSE:ELMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

In the previous week, CVRx had 1 more articles in the media than Electromed. MarketBeat recorded 3 mentions for CVRx and 2 mentions for Electromed. Electromed's average media sentiment score of 0.55 beat CVRx's score of 0.47 indicating that Electromed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Electromed	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Electromed has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$61.19M	1.34	-$53.31M	-$1.98	N/A
Electromed	$73.78M	3.20	$5.15M	$1.31	21.56

CVRx presently has a consensus price target of $5.30, indicating a potential upside of 72.64%. Electromed has a consensus price target of $43.75, indicating a potential upside of 54.92%. Given CVRx's higher probable upside, equities research analysts clearly believe CVRx is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

CVRx has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, Electromed has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

Electromed has a net margin of 11.34% compared to CVRx's net margin of -84.93%. Electromed's return on equity of 15.71% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Electromed	11.34%	15.71%	13.37%

75.3% of CVRx shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 16.6% of CVRx shares are held by company insiders. Comparatively, 10.5% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Electromed beats CVRx on 11 of the 16 factors compared between the two stocks.

How does CVRx compare to Avita Medical?

CVRx (NASDAQ:CVRX) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

Avita Medical has a net margin of -56.96% compared to CVRx's net margin of -84.93%. Avita Medical's return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Avita Medical	-56.96%	N/A	-78.53%

In the previous week, CVRx had 2 more articles in the media than Avita Medical. MarketBeat recorded 3 mentions for CVRx and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.00 beat CVRx's score of 0.47 indicating that Avita Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

75.3% of CVRx shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 16.6% of CVRx shares are held by company insiders. Comparatively, 2.2% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Avita Medical has higher revenue and earnings than CVRx. Avita Medical is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$61.19M	1.34	-$53.31M	-$1.98	N/A
Avita Medical	$71.61M	4.62	-$48.59M	-$1.44	N/A

CVRx currently has a consensus price target of $5.30, suggesting a potential upside of 72.64%. Avita Medical has a consensus price target of $11.40, suggesting a potential upside of 5.95%. Given CVRx's higher probable upside, equities analysts clearly believe CVRx is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

CVRx has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Avita Medical has a beta of 2.02, indicating that its share price is 102% more volatile than the broader market.

Summary

Avita Medical beats CVRx on 10 of the 16 factors compared between the two stocks.

How does CVRx compare to Orchestra BioMed?

CVRx (NASDAQ:CVRX) and Orchestra BioMed (NASDAQ:OBIO) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

CVRx currently has a consensus price target of $5.30, suggesting a potential upside of 72.64%. Orchestra BioMed has a consensus price target of $13.00, suggesting a potential upside of 162.63%. Given Orchestra BioMed's stronger consensus rating and higher probable upside, analysts clearly believe Orchestra BioMed is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Orchestra BioMed	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

CVRx has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Orchestra BioMed has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

Orchestra BioMed has lower revenue, but higher earnings than CVRx. Orchestra BioMed is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$61.19M	1.34	-$53.31M	-$1.98	N/A
Orchestra BioMed	$33.48M	8.89	-$52.70M	-$0.85	N/A

CVRx has a net margin of -84.93% compared to Orchestra BioMed's net margin of -184.60%. Orchestra BioMed's return on equity of -149.61% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Orchestra BioMed	-184.60%	-149.61%	-54.15%

In the previous week, Orchestra BioMed had 4 more articles in the media than CVRx. MarketBeat recorded 7 mentions for Orchestra BioMed and 3 mentions for CVRx. Orchestra BioMed's average media sentiment score of 1.19 beat CVRx's score of 0.47 indicating that Orchestra BioMed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Orchestra BioMed	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

75.3% of CVRx shares are held by institutional investors. Comparatively, 53.2% of Orchestra BioMed shares are held by institutional investors. 16.6% of CVRx shares are held by company insiders. Comparatively, 7.5% of Orchestra BioMed shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Orchestra BioMed beats CVRx on 9 of the 16 factors compared between the two stocks.

How does CVRx compare to Treace Medical Concepts?

CVRx (NASDAQ:CVRX) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

CVRx currently has a consensus target price of $5.30, suggesting a potential upside of 72.64%. Treace Medical Concepts has a consensus target price of $5.17, suggesting a potential upside of 10.00%. Given CVRx's stronger consensus rating and higher probable upside, analysts clearly believe CVRx is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

CVRx has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

75.3% of CVRx shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 16.6% of CVRx shares are owned by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

CVRx has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$61.19M	1.34	-$53.31M	-$1.98	N/A
Treace Medical Concepts	$212.69M	1.44	-$59M	-$0.93	N/A

Treace Medical Concepts has a net margin of -28.99% compared to CVRx's net margin of -84.93%. Treace Medical Concepts' return on equity of -71.37% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

In the previous week, CVRx had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 3 mentions for CVRx and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.34 beat CVRx's score of 0.47 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Treace Medical Concepts beats CVRx on 10 of the 16 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CVRX vs. The Competition

Export

Metric	CVRx	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$80.99M	$5.75B	$7.21B	$12.67B
Dividend Yield	N/A	1.75%	2.53%	8.56%
P/E Ratio	-1.55	25.86	272.66	25.23
Price / Sales	1.34	80.80	635.76	104.55
Price / Cash	N/A	33.05	76.98	52.08
Price / Book	4.09	6.08	12.83	6.10
Net Income	-$53.31M	$147.75M	$3.47B	$348.86M
7 Day Performance	0.99%	-0.74%	-0.12%	-1.90%
1 Month Performance	-44.18%	3.77%	6.74%	1.96%
1 Year Performance	-60.74%	7.38%	25.09%	15.30%

CVRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CVRX CVRx	3.5811 of 5 stars	$3.07 +1.0%	$5.30 +72.6%	-60.3%	$80.99M	$61.19M	N/A	160
MOBI Mobia Medical	3.9032 of 5 stars	$10.63 -3.2%	$20.75 +95.2%	N/A	$353.87M	$32.04M	N/A	N/A	Positive News
ELMD Electromed	2.9636 of 5 stars	$39.34 -2.4%	$37.50 -4.7%	+17.9%	$325.74M	$71.75M	52.45	160	News Coverage Positive News
RCEL Avita Medical	2.4838 of 5 stars	$10.50 +6.0%	$10.20 -2.9%	+150.8%	$323.19M	$71.61M	N/A	130	Positive News
OBIO Orchestra BioMed	3.275 of 5 stars	$5.36 -1.5%	$13.00 +142.5%	+80.7%	$322.14M	$33.48M	N/A	4	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CVRX) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CVRx (CVRX) Competitors